Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Endocr J ; 66(1): 107-114, 2019 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-30393272

RESUMEN

Soft-drink diabetic ketosis, characterized by acute onset ketosis induced by excessive ingestion of sugar-containing drinks, is often seen in obese, young patients, even with undiagnosed type 2 diabetes. We herein report a 15-year-old obese patient with the apolipoprotein E4/2 phenotype, in whom eruptive xanthomas lead to a diagnosis of soft-drink diabetic ketosis. He developed multiple asymptomatic yellowish papules on the auricles, back, buttocks and the extensor surfaces of the elbows and knees. He initially visited a dermatology clinic and his blood triglyceride and HbA1c levels were found to be 6,490 mg/dL and 16.5%, respectively. He was referred to our hospital for treatment of hyperglycemia and hypertyriglyceridemia. On admission, he had ketonuria and increased blood levels of 3-hydroxybutylate and acetoacetate. He habitually drank 1-3 litters of sweet beverages daily to quench his thirst. Therefore, "soft-drink diabetic ketosis" was diagnosed. Severe hypertriglyceridemia was considered to have been a consequence of impaired insulin action and his apolipoprotein E4/2 phenotype. We treated the diabetic ketosis and hypertriglyceridemia with intensive insulin therapy and a fat-restricted diet. At discharge, he no longer required insulin therapy and his blood glucose levels were controlled with metformin and voglibose. Along with amelioration of the hyperglycemia, triglyceride levels decreased to 247 mg/dL without administration of anti-hyperlipidemia agents. The eruptive xanthoma lesions gradually diminished in size and number and eventually disappeared by 12 months. This case provides an instructive example of eruptive xanthomas serving as a sign of severe dysregulation, not only of lipid, but also glucose, metabolism.


Asunto(s)
Diabetes Mellitus Tipo 2/diagnóstico , Cetoacidosis Diabética/diagnóstico , Hipertrigliceridemia/diagnóstico , Xantomatosis/diagnóstico , Ácido 3-Hidroxibutírico/sangre , Acetoacetatos/sangre , Adolescente , Apolipoproteína E2 , Apolipoproteína E4 , Bebidas Gaseosas/efectos adversos , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Cetoacidosis Diabética/tratamiento farmacológico , Cetoacidosis Diabética/etiología , Cetoacidosis Diabética/metabolismo , Dieta con Restricción de Grasas , Hemoglobina Glucada/metabolismo , Humanos , Hipertrigliceridemia/complicaciones , Hipertrigliceridemia/dietoterapia , Hipertrigliceridemia/metabolismo , Hipoglucemiantes/uso terapéutico , Inositol/análogos & derivados , Inositol/uso terapéutico , Insulina/uso terapéutico , Cetosis/diagnóstico , Cetosis/etiología , Masculino , Metformina/uso terapéutico , Obesidad/complicaciones , Obesidad/metabolismo , Xantomatosis/etiología , Xantomatosis/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA